Filtered By:
Source: European Review for Medical and Pharmacological Sciences
Infectious Disease: SARS
This page shows you your search results in order of date.
Order by Relevance | Date
Total 140 results found since Jan 2013.
An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?
CONCLUSIONS: Given the autoimmune pathogenesis of the disease, we discussed the potential role of SARS-CoV-2 infection and vaccination as a trigger for the development of hair loss. Physicians should be aware of SARS-CoV-2 vaccine-related hair loss and properly treat this undesirable effect.PMID:36647894 | DOI:10.26355/eurrev_202301_30900
Source: European Review for Medical and Pharmacological Sciences - January 17, 2023 Category: Drugs & Pharmacology Authors: L Peterle L Macca F Li Pomi F Vaccaro F Borgia M Vaccaro Source Type: research
Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review
CONCLUSIONS: Despite differences in the published research, CHX at different concentrations may be effective in lowering the SARS-COV-2 viral load in saliva.PMID:36647885 | DOI:10.26355/eurrev_202301_30890
Source: European Review for Medical and Pharmacological Sciences - January 17, 2023 Category: Drugs & Pharmacology Authors: G S Rahman A A N Alshetan S S O Alotaibi B M I Alaskar M A Baseer Source Type: research
An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?
CONCLUSIONS: Given the autoimmune pathogenesis of the disease, we discussed the potential role of SARS-CoV-2 infection and vaccination as a trigger for the development of hair loss. Physicians should be aware of SARS-CoV-2 vaccine-related hair loss and properly treat this undesirable effect.PMID:36647894 | DOI:10.26355/eurrev_202301_30900
Source: European Review for Medical and Pharmacological Sciences - January 17, 2023 Category: Drugs & Pharmacology Authors: L Peterle L Macca F Li Pomi F Vaccaro F Borgia M Vaccaro Source Type: research
Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review
CONCLUSIONS: Despite differences in the published research, CHX at different concentrations may be effective in lowering the SARS-COV-2 viral load in saliva.PMID:36647885 | DOI:10.26355/eurrev_202301_30890
Source: European Review for Medical and Pharmacological Sciences - January 17, 2023 Category: Drugs & Pharmacology Authors: G S Rahman A A N Alshetan S S O Alotaibi B M I Alaskar M A Baseer Source Type: research
COVID-19 and neurodegenerative diseases
CONCLUSIONS: Some patients with neurodegenerative diseases have already shown more susceptibility to SARS-CoV-2 infection and significantly higher mortality due to the elderly population with underlying diseases. Moreover, SARS-CoV-2 could cause damage to the central nervous system (CNS) that may substantially increase the incidence of neurodegenerative diseases and accelerate the progression of them.PMID:35776055 | DOI:10.26355/eurrev_202206_29093
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: Y-W Fu H-S Xu S-J Liu Source Type: research
Hematological aspects of the COVID-19 syndrome
CONCLUSIONS: The final episode of this pandemic will include the "chimerism-mediated immunotherapy" that will eventually lead to end of the COVID-19 process. The recent Omicron variant seems to have unique evasion effects on the interferon gene expression which will boost the chimerism-mediated immunotherapy without high mortality rates.PMID:35776048 | DOI:10.26355/eurrev_202206_29086
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research
COVID-19 and neurodegenerative diseases
CONCLUSIONS: Some patients with neurodegenerative diseases have already shown more susceptibility to SARS-CoV-2 infection and significantly higher mortality due to the elderly population with underlying diseases. Moreover, SARS-CoV-2 could cause damage to the central nervous system (CNS) that may substantially increase the incidence of neurodegenerative diseases and accelerate the progression of them.PMID:35776055 | DOI:10.26355/eurrev_202206_29093
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: Y-W Fu H-S Xu S-J Liu Source Type: research
Hematological aspects of the COVID-19 syndrome
CONCLUSIONS: The final episode of this pandemic will include the "chimerism-mediated immunotherapy" that will eventually lead to end of the COVID-19 process. The recent Omicron variant seems to have unique evasion effects on the interferon gene expression which will boost the chimerism-mediated immunotherapy without high mortality rates.PMID:35776048 | DOI:10.26355/eurrev_202206_29086
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research
COVID-19 and neurodegenerative diseases
CONCLUSIONS: Some patients with neurodegenerative diseases have already shown more susceptibility to SARS-CoV-2 infection and significantly higher mortality due to the elderly population with underlying diseases. Moreover, SARS-CoV-2 could cause damage to the central nervous system (CNS) that may substantially increase the incidence of neurodegenerative diseases and accelerate the progression of them.PMID:35776055 | DOI:10.26355/eurrev_202206_29093
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: Y-W Fu H-S Xu S-J Liu Source Type: research
Hematological aspects of the COVID-19 syndrome
CONCLUSIONS: The final episode of this pandemic will include the "chimerism-mediated immunotherapy" that will eventually lead to end of the COVID-19 process. The recent Omicron variant seems to have unique evasion effects on the interferon gene expression which will boost the chimerism-mediated immunotherapy without high mortality rates.PMID:35776048 | DOI:10.26355/eurrev_202206_29086
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research
COVID-19 and neurodegenerative diseases
CONCLUSIONS: Some patients with neurodegenerative diseases have already shown more susceptibility to SARS-CoV-2 infection and significantly higher mortality due to the elderly population with underlying diseases. Moreover, SARS-CoV-2 could cause damage to the central nervous system (CNS) that may substantially increase the incidence of neurodegenerative diseases and accelerate the progression of them.PMID:35776055 | DOI:10.26355/eurrev_202206_29093
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: Y-W Fu H-S Xu S-J Liu Source Type: research
Hematological aspects of the COVID-19 syndrome
CONCLUSIONS: The final episode of this pandemic will include the "chimerism-mediated immunotherapy" that will eventually lead to end of the COVID-19 process. The recent Omicron variant seems to have unique evasion effects on the interferon gene expression which will boost the chimerism-mediated immunotherapy without high mortality rates.PMID:35776048 | DOI:10.26355/eurrev_202206_29086
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research
